NetLib Security, a leader in transparent data encryption, today announced the general availability of Encryptionizer Winter 2026, alongside significant upgrades to the Encryptionizer Key Manager (EKM) ...

Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...